Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Daidzein is an isoflavonoid phytoestrogen found primarily in soybeans that acts as a selective estrogen receptor modulator. It activates PPAR transcription factors and exhibits weak estrogenic activity through binding to estrogen receptors alpha and beta.
Origin & History
Daidzein is a naturally occurring isoflavone found primarily in soybeans (Glycine max) and other legumes such as kudzu (Pueraria lobata), comprising about 37% of total isoflavones in soybeans. It is produced in plants via the phenylpropanoid pathway starting from L-phenylalanine, involving enzymes like chalcone synthase and isoflavone synthase, and is typically extracted from soy foods or supplements where it exists as the aglycone form released from its glucoside daidzin.
Research Narrative (Provisional)
The research dossier notably lacks specific details on human clinical trials, RCTs, or meta-analyses for daidzein, with no PubMed PMIDs provided for study designs, sample sizes, or clinical outcomes. While daidzein is recognized as a phytoestrogen from soy with metabolism to equol or O-DMA by gut bacteria in some populations, concrete trial data is absent from the available research.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Daidzein is a pure isoflavone compound (aglycone form), not a whole food, so macronutrient/micronutrient framing is not applicable. Key chemical and bioactive profile: Molecular formula C15H10O4, molecular weight 254.24 g/mol. Found naturally in soybeans at approximately 0.1–3.0 mg/g dry weight (varies by cultivar and processing). In soy foods: tofu contains roughly 8–50 mg daidzein per 100g, tempeh 19–62 mg/100g (fermentation increases aglycone bioavailability), miso 16–40 mg/100g, and soy milk 2–15 mg/100g. As an aglycone, daidzein has superior bioavailability (~20–55% absorption) compared to its glycoside form daidzin, which requires intestinal beta-glucosidase cleavage before absorption. Peak plasma concentration typically reached within 6–8 hours post-ingestion. Classified as a phytoestrogen isoflavone with estrogenic binding affinity (Ki ~0.1–1.0 µM for ERβ, lower affinity for ERα). Lipophilicity (LogP ~2.5) allows passive intestinal absorption. Hepatic metabolism involves glucuronidation and sulfation. Approximately 30–50% of individuals harbor gut microbiota (Lactonifactor longoviformis, Slackia isoflavoniconvertens) capable of converting daidzein to the more potent metabolite equol. No fiber, protein, vitamins, or minerals are inherently associated with daidzein as an isolated compound.
Reported Mechanism (Provisional)
Daidzein binds to estrogen receptors alpha and beta with greater affinity for ER-β, acting as a selective estrogen receptor modulator depending on tissue context. It transactivates all three PPAR isoforms (α, δ, γ), influencing lipid metabolism, glucose homeostasis, and cellular energy production. The compound also modulates aromatase activity and can be metabolized by gut bacteria into the more potent metabolite equol.
Clinical Narrative (Provisional)
Clinical studies on daidzein have primarily focused on postmenopausal women, with trials typically ranging from 50-200 subjects over 12-24 week periods. Research suggests potential benefits for bone mineral density preservation and modest improvements in lipid profiles, though results are mixed and often confounded by overall soy isoflavone intake. Most studies use doses between 40-80mg daily, often as part of broader isoflavone supplementation. The evidence quality remains moderate due to heterogeneous study designs and variable bioavailability across populations.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.